Table 3.
Neuro-QoL Short Form | QOLIE-31 | Liverpool Seizure Severity Scale | Liverpool Adverse Events Profile | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Total | Cognitive | Energy/ Fatigue | Emotional Well- Being | Medication Effects | Overall Quality of Life | Social Function | Seizure Worry | |||
Positive Affect & Well Being | .74 ** | .52 ** | .54 ** | .67 ** | .42 ** | .62 ** | .64 ** | .52 ** | −.36 ** | −.60 ** |
Applied Cognition – General Concerns | .68 ** | .78 ** | .53 ** | .43 ** | .43 ** | .42 ** | .39 ** | .40 ** | −.19 | −.70 ** |
Applied Cognition – Executive Function | .57 ** | .67 ** | .40 ** | .42 ** | .26 ** | .41 ** | .35 ** | .25 ** | .01 | −.51 ** |
Lower Extremity Function - Mobility | .33 ** | .34 ** | .28 ** | .18 | .21 * | .17 | .25 ** | .21 * | −.20 | −.39 ** |
Upper Extremity Function - Fine Motor, ADL | .33 ** | .28 ** | .27 ** | .21 * | .12 | .21 * | .30 ** | .23 * | −.21 | −.36 ** |
Ability to Participate in Social Roles and Activities | .65 ** | .49 ** | .47 ** | .54 ** | .42 ** | .46 ** | .60 ** | .43 ** | −.31 * | −.52 ** |
Satisfaction with Social Roles and Activities | .54 ** | .39 ** | .47 ** | .46 ** | .32 ** | .38 ** | .49 ** | .41 ** | −0.22 | −.34 ** |
Depression | −.64 ** | −.43 ** | −.52 ** | −.70 ** | −.31 ** | −.57 ** | −.52 ** | −.44 ** | .39 ** | .45 ** |
Anxiety | −.62 ** | −.42 ** | −.53 ** | −.69 ** | −.35 ** | −.45 ** | −.48 ** | −.55 ** | .44 ** | .48 ** |
Stigma | −.58 ** | −.37 ** | −.42 ** | −.50 ** | −.37 ** | −.42 ** | −.57 ** | −.50 ** | .41 ** | .48 ** |
Fatigue | −.59 ** | −.41 ** | −.67 ** | −.44 ** | −.38 ** | −.30 ** | −.50 ** | −.51 ** | .49 ** | .61 ** |
Sleep Disturbance | −.53 ** | −.41 ** | −.46 ** | −.42 ** | −.37 ** | −.33 ** | −.43 ** | −.47 ** | .38 ** | .63 ** |
Emotional & Behavioral Dyscontrol | −.58 ** | −.48 ** | −.45 ** | −.54 ** | −.34 ** | −.39 ** | −.48 ** | −.39 ** | .33 * | .55 ** |
p < .05;
p < .01